A Southampton woman has shared her harrowing experience after a popular weight-loss injection left her hospitalised and fighting for her life. Thirty-four-year-old Aimee Chapman says she suffered catastrophic side effects including liver failure, malnutrition, and hair loss, all in pursuit of improved health and better treatment from medical professionals.
Aimee’s journey began in early March last year, when she discovered the now widely-circulated GLP-1 weight-loss injections via a post on social media. The drugs, originally intended for managing diabetes, have been increasingly used as appetite suppressants for those seeking to lose weight. Hoping a lower number on the scales might result in being “taken more seriously” by the medical establishment, she purchased a month’s supply online for approximately £200, following a legal and regulated process through an online pharmacy.
Initially, the results appeared impressive. Within four months, Aimee had shed four stone, dropping from 14 stone to 10 stone. But in June, her health began to deteriorate rapidly. “I noticed my energy was gone, I barely ate and could hardly walk,” Aimee recalls. Most alarmingly, she started to vomit frequently—sometimes more than 60 times in quick succession. As her symptoms intensified, including chest pains and blackout episodes, her husband found her collapsed at home, which prompted her to seek emergency care.
The medical situation quickly escalated. Upon admission to Winchester Hospital’s A&E, doctors identified a perforation in her oesophagus, caused by the relentless vomiting, which had allowed air to escape around her heart and lungs. In a further devastating blow, blood tests revealed her liver was in acute distress—so much so that clinicians began discussing the possibility of an organ transplant should her condition fail to improve.
Aimee spent 11 days under close observation in hospital. Despite being discharged, she soon noticed further troubling signs: her hair, once reaching down her back, began falling out in large clumps. The hair loss, later attributed to a severe vitamin B12 deficiency, compounded the physical and emotional toll the experience was taking on her. “My hair was such a key part of my identity,” she explained, recounting the trauma of eventually having it all cut off.
Medical staff confirmed to Aimee that her liver problems and oesophageal injury were most likely linked to side effects from the weight-loss injections. Yet, the incident exposed a gap in medical knowledge about the full extent or causes of such reactions with these medications. “They said I could never take one of these jabs again, not even for diabetes,” Aimee recounted, highlighting the deep uncertainty healthcare providers themselves are facing with this new class of drugs.
Reflecting on her ordeal, Aimee says that, for her, the motivation was never about looks. “It wasn’t about being thinner, but about being listened to,” she said, voicing a concern that resonates with many people struggling to access adequate care in a system that can appear to judge by weight. However, her advice for anyone considering weight-loss injectables is unequivocal: seek medical supervision and do not purchase these treatments online, however legitimate the source may appear.
Aimee’s case is a sombre reminder of the risks that can accompany even regulated, widely-publicised treatments when used outside of carefully supervised medical environments. While GLP-1-based medications have provided significant benefits to some, the long-term effects—especially in people without diabetes—are still not fully understood, and adverse reactions may become more widely reported as use increases.
Calls are now growing for more comprehensive research into the safety profile of these drugs, particularly for off-label weight loss, and for greater public awareness about the potential side effects. Aimee’s hope is that her story serves as a cautionary tale, empowering others to make informed decisions and consult clinical professionals before beginning any new regimen or therapy.
As the popularity of injectable weight-loss solutions continues to rise across the UK, medical professionals and patients alike are wrestling with questions about safety, efficacy, and proper oversight—a debate made all the more urgent by the kind of life-changing consequences Aimee has endured.